A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUNHOZ, Rodrigo Ramella e ROELA, Rosimeire Aparecida e BRENTANI, Maria Mitzi. Uma breve história do câncer. Oncologia - da molécula à clínica. Tradução . São Paulo: Editora dos Editores, 2022. . . Acesso em: 07 jul. 2024.
APA
Munhoz, R. R., Roela, R. A., & Brentani, M. M. (2022). Uma breve história do câncer. In Oncologia - da molécula à clínica. São Paulo: Editora dos Editores.
NLM
Munhoz RR, Roela RA, Brentani MM. Uma breve história do câncer. In: Oncologia - da molécula à clínica. São Paulo: Editora dos Editores; 2022. [citado 2024 jul. 07 ]
Vancouver
Munhoz RR, Roela RA, Brentani MM. Uma breve história do câncer. In: Oncologia - da molécula à clínica. São Paulo: Editora dos Editores; 2022. [citado 2024 jul. 07 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KATAYAMA, Maria Lucia Hirata et al. Stromal cell signature associated with response to neoadjuvant chemotherapy in locally advanced breast cancer. Cells, v. 8, n. 12, 2019Tradução . . Disponível em: https://doi.org/10.3390/cells8121566. Acesso em: 07 jul. 2024.
APA
Katayama, M. L. H., Vieira, R. A. da C., Andrade, V. P., Roela, R. A., Lima, L. G. C. A., Kerr, L. M., et al. (2019). Stromal cell signature associated with response to neoadjuvant chemotherapy in locally advanced breast cancer. Cells, 8( 12). doi:10.3390/cells8121566
NLM
Katayama MLH, Vieira RA da C, Andrade VP, Roela RA, Lima LGCA, Kerr LM, Polpo A, Pereira CA de B, Serio PA de MP, Encinas G, Maistro S, Petroni M de AL, Brentani MM, Folgueira MAAK. Stromal cell signature associated with response to neoadjuvant chemotherapy in locally advanced breast cancer [Internet]. Cells. 2019 ; 8( 12):[citado 2024 jul. 07 ] Available from: https://doi.org/10.3390/cells8121566
Vancouver
Katayama MLH, Vieira RA da C, Andrade VP, Roela RA, Lima LGCA, Kerr LM, Polpo A, Pereira CA de B, Serio PA de MP, Encinas G, Maistro S, Petroni M de AL, Brentani MM, Folgueira MAAK. Stromal cell signature associated with response to neoadjuvant chemotherapy in locally advanced breast cancer [Internet]. Cells. 2019 ; 8( 12):[citado 2024 jul. 07 ] Available from: https://doi.org/10.3390/cells8121566
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOGULLO, Angela Flávia et al. Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes: A large diagnostic study using tissue microarray: a large diagnostic study using tissue microarray. Molecular and Clinical Oncology, 2018Tradução . . Disponível em: https://doi.org/10.3892/mco.2018.1685. Acesso em: 07 jul. 2024.
APA
Logullo, A. F., Pasini, F. S., Nonogaki, S., Rocha, R. M., Soares, F. A., & Brentani, M. M. (2018). Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes: A large diagnostic study using tissue microarray: a large diagnostic study using tissue microarray. Molecular and Clinical Oncology. doi:10.3892/mco.2018.1685
NLM
Logullo AF, Pasini FS, Nonogaki S, Rocha RM, Soares FA, Brentani MM. Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes: A large diagnostic study using tissue microarray: a large diagnostic study using tissue microarray [Internet]. Molecular and Clinical Oncology. 2018 ;[citado 2024 jul. 07 ] Available from: https://doi.org/10.3892/mco.2018.1685
Vancouver
Logullo AF, Pasini FS, Nonogaki S, Rocha RM, Soares FA, Brentani MM. Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes: A large diagnostic study using tissue microarray: a large diagnostic study using tissue microarray [Internet]. Molecular and Clinical Oncology. 2018 ;[citado 2024 jul. 07 ] Available from: https://doi.org/10.3892/mco.2018.1685
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ENCINAS, G. et al. Somatic mutations in early onset luminal breast cancer. Oncotarget, v. 9, n. 32, p. 22460-22479, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.25123. Acesso em: 07 jul. 2024.
APA
Encinas, G., Sabelnykova, V. Y., Lyra, E. C. de, Katayama, M. L. H., Maistro, S., Valle, P. W. M. V., et al. (2018). Somatic mutations in early onset luminal breast cancer. Oncotarget, 9( 32), 22460-22479. doi:10.18632/oncotarget.25123
NLM
Encinas G, Sabelnykova VY, Lyra EC de, Katayama MLH, Maistro S, Valle PWMV, Pereira GFL, Rodrigues LM, Serio PAMP, Gouvêa ACRC de, Pasini FS, Brentani MM, Chammas R, Folgueira MAAK. Somatic mutations in early onset luminal breast cancer [Internet]. Oncotarget. 2018 ; 9( 32): 22460-22479.[citado 2024 jul. 07 ] Available from: https://doi.org/10.18632/oncotarget.25123
Vancouver
Encinas G, Sabelnykova VY, Lyra EC de, Katayama MLH, Maistro S, Valle PWMV, Pereira GFL, Rodrigues LM, Serio PAMP, Gouvêa ACRC de, Pasini FS, Brentani MM, Chammas R, Folgueira MAAK. Somatic mutations in early onset luminal breast cancer [Internet]. Oncotarget. 2018 ; 9( 32): 22460-22479.[citado 2024 jul. 07 ] Available from: https://doi.org/10.18632/oncotarget.25123
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARRARA, Guilherme Freire Angotti et al. Breast-conserving surgery in locally advanced breast cancer submitted to neoadjuvant chemotherapy. Safety and effectiveness based on ipsilateral breast tumor recurrence and long-term follow-up. Clinics, v. 72, n. 3, p. 134-142, 2017Tradução . . Disponível em: https://doi.org/10.6061/clinics/2017(03)02. Acesso em: 07 jul. 2024.
APA
Carrara, G. F. A., Scapulatempo-Neto, C., Abrahão-Machado, L. F., Brentani, M. M., Nunes, J. S., Folgueira, M. A. A. K., & Vieira, R. A. da C. (2017). Breast-conserving surgery in locally advanced breast cancer submitted to neoadjuvant chemotherapy. Safety and effectiveness based on ipsilateral breast tumor recurrence and long-term follow-up. Clinics, 72( 3), 134-142. doi:10.6061/clinics/2017(03)02
NLM
Carrara GFA, Scapulatempo-Neto C, Abrahão-Machado LF, Brentani MM, Nunes JS, Folgueira MAAK, Vieira RA da C. Breast-conserving surgery in locally advanced breast cancer submitted to neoadjuvant chemotherapy. Safety and effectiveness based on ipsilateral breast tumor recurrence and long-term follow-up [Internet]. Clinics. 2017 ; 72( 3): 134-142.[citado 2024 jul. 07 ] Available from: https://doi.org/10.6061/clinics/2017(03)02
Vancouver
Carrara GFA, Scapulatempo-Neto C, Abrahão-Machado LF, Brentani MM, Nunes JS, Folgueira MAAK, Vieira RA da C. Breast-conserving surgery in locally advanced breast cancer submitted to neoadjuvant chemotherapy. Safety and effectiveness based on ipsilateral breast tumor recurrence and long-term follow-up [Internet]. Clinics. 2017 ; 72( 3): 134-142.[citado 2024 jul. 07 ] Available from: https://doi.org/10.6061/clinics/2017(03)02
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTOS, E. P. et al. A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer. PLOS ONE, v. 11, n. 4, p. 21 , 2016Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0154325. Acesso em: 07 jul. 2024.
APA
Bastos, E. P., Brentani, H., Pereira, C. A. de B., Polpo, A., Lima, L., Puga, R. D., et al. (2016). A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer. PLOS ONE, 11( 4), 21 . doi:10.1371/journal.pone.0154325
NLM
Bastos EP, Brentani H, Pereira CA de B, Polpo A, Lima L, Puga RD, Pasini FS, Osorio CABT, Roela RA, Achatz MI, Trapé AP, Gonzalez-Angulo AM, Brentani MM. A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer [Internet]. PLOS ONE. 2016 ; 11( 4): 21 .[citado 2024 jul. 07 ] Available from: https://doi.org/10.1371/journal.pone.0154325
Vancouver
Bastos EP, Brentani H, Pereira CA de B, Polpo A, Lima L, Puga RD, Pasini FS, Osorio CABT, Roela RA, Achatz MI, Trapé AP, Gonzalez-Angulo AM, Brentani MM. A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer [Internet]. PLOS ONE. 2016 ; 11( 4): 21 .[citado 2024 jul. 07 ] Available from: https://doi.org/10.1371/journal.pone.0154325
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROZENCHAN, Patricia Bortman et al. Specific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer. Tumor Biology, v. 36, n. 12, p. 9589-9597, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007/s13277-015-3727-1. Acesso em: 07 jul. 2024.
APA
Rozenchan, P. B., Pasini, F. S., Roela, R. A., Katayama, M. L. H., Mundim, F. G. L., Brentani, H., et al. (2015). Specific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer. Tumor Biology, 36( 12), 9589-9597. doi:10.1007/s13277-015-3727-1
NLM
Rozenchan PB, Pasini FS, Roela RA, Katayama MLH, Mundim FGL, Brentani H, Lyra EC, Brentani MM. Specific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer [Internet]. Tumor Biology. 2015 ; 36( 12): 9589-9597.[citado 2024 jul. 07 ] Available from: http://link.springer.com/article/10.1007/s13277-015-3727-1
Vancouver
Rozenchan PB, Pasini FS, Roela RA, Katayama MLH, Mundim FGL, Brentani H, Lyra EC, Brentani MM. Specific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer [Internet]. Tumor Biology. 2015 ; 36( 12): 9589-9597.[citado 2024 jul. 07 ] Available from: http://link.springer.com/article/10.1007/s13277-015-3727-1
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ENCINAS, Giselly et al. Somatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysis. Revista da Associação Médica Brasileira, v. 61, n. 5, p. 474-483, 2015Tradução . . Disponível em: https://doi.org/10.1590/1806-9282.61.05.474. Acesso em: 07 jul. 2024.
APA
Encinas, G., Maistro, S., Pasini, F. S., Katayama, M. L. H., Brentani, M. M., Bock, G. H. de, & Folgueira, M. A. A. K. (2015). Somatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysis. Revista da Associação Médica Brasileira, 61( 5), 474-483. doi:10.1590/1806-9282.61.05.474
NLM
Encinas G, Maistro S, Pasini FS, Katayama MLH, Brentani MM, Bock GH de, Folgueira MAAK. Somatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysis [Internet]. Revista da Associação Médica Brasileira. 2015 ; 61( 5): 474-483.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1590/1806-9282.61.05.474
Vancouver
Encinas G, Maistro S, Pasini FS, Katayama MLH, Brentani MM, Bock GH de, Folgueira MAAK. Somatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysis [Internet]. Revista da Associação Médica Brasileira. 2015 ; 61( 5): 474-483.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1590/1806-9282.61.05.474
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ENCINAS, Giselly et al. Somatic mutations in Luminal HER2 negative tumors from young breast cancer patients. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/1544?sid=ef1e190f-d5ee-4417-942f-c3e8a7c0c046. Acesso em: 07 jul. 2024. , 2015
APA
Encinas, G., Estevez-Diz, M. D. P., Lyra, E. C., Katayama, M. L. H., Pasini, F. S., Maistro, S., et al. (2015). Somatic mutations in Luminal HER2 negative tumors from young breast cancer patients. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/1544?sid=ef1e190f-d5ee-4417-942f-c3e8a7c0c046
NLM
Encinas G, Estevez-Diz MDP, Lyra EC, Katayama MLH, Pasini FS, Maistro S, Sabelnykova V, Boutros P, Brentani MM, Basso R, De Gouvea ACRC, Chammas R, Goes JCGS, Folgueira MAAK. Somatic mutations in Luminal HER2 negative tumors from young breast cancer patients [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2024 jul. 07 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/1544?sid=ef1e190f-d5ee-4417-942f-c3e8a7c0c046
Vancouver
Encinas G, Estevez-Diz MDP, Lyra EC, Katayama MLH, Pasini FS, Maistro S, Sabelnykova V, Boutros P, Brentani MM, Basso R, De Gouvea ACRC, Chammas R, Goes JCGS, Folgueira MAAK. Somatic mutations in Luminal HER2 negative tumors from young breast cancer patients [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2024 jul. 07 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/1544?sid=ef1e190f-d5ee-4417-942f-c3e8a7c0c046
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARRARA, G. F. A. et al. Ipsilateral breast cancer recurrence in conservative treatment for locally advanced breast cancer. The Breast. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0960-9776(15)70240-7. Acesso em: 07 jul. 2024. , 2015
APA
Carrara, G. F. A., Neto, C. S., Abrão-Machado, L. F., Nunes, J. S., Folgueira, M. A. A. K., Brentani, M. M., & Vieira, R. A. C. (2015). Ipsilateral breast cancer recurrence in conservative treatment for locally advanced breast cancer. The Breast. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0960-9776(15)70240-7
NLM
Carrara GFA, Neto CS, Abrão-Machado LF, Nunes JS, Folgueira MAAK, Brentani MM, Vieira RAC. Ipsilateral breast cancer recurrence in conservative treatment for locally advanced breast cancer [Internet]. The Breast. 2015 ; 24( supl. 1): S96.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1016/S0960-9776(15)70240-7
Vancouver
Carrara GFA, Neto CS, Abrão-Machado LF, Nunes JS, Folgueira MAAK, Brentani MM, Vieira RAC. Ipsilateral breast cancer recurrence in conservative treatment for locally advanced breast cancer [Internet]. The Breast. 2015 ; 24( supl. 1): S96.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1016/S0960-9776(15)70240-7
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUNDIM, Fiorita G. L. et al. Metastatic lymph node fibroblasts maintain similar profile of stromal biomarkers registered in primary breast carcinomas. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.SABCS14-P4-04-24. Acesso em: 07 jul. 2024. , 2015
APA
Mundim, F. G. L., Pasini, F. S., Nonogaki, S., Soares, F. A., Brentani, M. M., & Logullo, A. F. (2015). Metastatic lymph node fibroblasts maintain similar profile of stromal biomarkers registered in primary breast carcinomas. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. doi:10.1158/1538-7445.SABCS14-P4-04-24
NLM
Mundim FGL, Pasini FS, Nonogaki S, Soares FA, Brentani MM, Logullo AF. Metastatic lymph node fibroblasts maintain similar profile of stromal biomarkers registered in primary breast carcinomas [Internet]. Cancer Research. 2015 ; 75[citado 2024 jul. 07 ] Available from: https://doi.org/10.1158/1538-7445.SABCS14-P4-04-24
Vancouver
Mundim FGL, Pasini FS, Nonogaki S, Soares FA, Brentani MM, Logullo AF. Metastatic lymph node fibroblasts maintain similar profile of stromal biomarkers registered in primary breast carcinomas [Internet]. Cancer Research. 2015 ; 75[citado 2024 jul. 07 ] Available from: https://doi.org/10.1158/1538-7445.SABCS14-P4-04-24
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FIGUEIREDO, Nancy Bueno et al. Estrogen-Responsive Genes Overlap with Triiodothyronine-Responsive Genes in a Breast Carcinoma Cell Line,. Scientific World Journal, v. 2014, p. 7 , 2014Tradução . . Disponível em: https://doi.org/10.1155/2014/969404. Acesso em: 07 jul. 2024.
APA
Figueiredo, N. B., Cestari, S. H., Conde, S. J., Luvizotto, R. A. M., De Sibio, M. T., Perone, D., et al. (2014). Estrogen-Responsive Genes Overlap with Triiodothyronine-Responsive Genes in a Breast Carcinoma Cell Line,. Scientific World Journal, 2014, 7 . doi:10.1155/2014/969404
NLM
Figueiredo NB, Cestari SH, Conde SJ, Luvizotto RAM, De Sibio MT, Perone D, Katayama MLH, Carraro DM, Brentani HP, Brentani MM, Nogueira CR. Estrogen-Responsive Genes Overlap with Triiodothyronine-Responsive Genes in a Breast Carcinoma Cell Line, [Internet]. Scientific World Journal. 2014 ; 2014 7 .[citado 2024 jul. 07 ] Available from: https://doi.org/10.1155/2014/969404
Vancouver
Figueiredo NB, Cestari SH, Conde SJ, Luvizotto RAM, De Sibio MT, Perone D, Katayama MLH, Carraro DM, Brentani HP, Brentani MM, Nogueira CR. Estrogen-Responsive Genes Overlap with Triiodothyronine-Responsive Genes in a Breast Carcinoma Cell Line, [Internet]. Scientific World Journal. 2014 ; 2014 7 .[citado 2024 jul. 07 ] Available from: https://doi.org/10.1155/2014/969404
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROZENCHAN, Patricia Bortman et al. RHOA, RAC1 and PAK1 evaluation in paired stromal fibroblasts of breast cancer primary and of lymph node metastasis: Importance of these biomarkers in lymph node invasion. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://cancerres.aacrjournals.org/content/74/19_Supplement/186. Acesso em: 07 jul. 2024. , 2014
APA
Rozenchan, P. B., Mundim, F. G., Roela, R. A., Katayama, M. L., Pasini, F. S., Brentani, H., et al. (2014). RHOA, RAC1 and PAK1 evaluation in paired stromal fibroblasts of breast cancer primary and of lymph node metastasis: Importance of these biomarkers in lymph node invasion. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://cancerres.aacrjournals.org/content/74/19_Supplement/186
NLM
Rozenchan PB, Mundim FG, Roela RA, Katayama ML, Pasini FS, Brentani H, Lyra EC, Folgueira MAAK, Brentani MM. RHOA, RAC1 and PAK1 evaluation in paired stromal fibroblasts of breast cancer primary and of lymph node metastasis: Importance of these biomarkers in lymph node invasion [Internet]. Cancer Research. 2014 ; 74[citado 2024 jul. 07 ] Available from: http://cancerres.aacrjournals.org/content/74/19_Supplement/186
Vancouver
Rozenchan PB, Mundim FG, Roela RA, Katayama ML, Pasini FS, Brentani H, Lyra EC, Folgueira MAAK, Brentani MM. RHOA, RAC1 and PAK1 evaluation in paired stromal fibroblasts of breast cancer primary and of lymph node metastasis: Importance of these biomarkers in lymph node invasion [Internet]. Cancer Research. 2014 ; 74[citado 2024 jul. 07 ] Available from: http://cancerres.aacrjournals.org/content/74/19_Supplement/186
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
URATA, Yuri Nagamine et al. Calcitriol supplementation effects on Ki67 expression and transcriptional profile of breast cancer specimens from post-menopausal patients. Clinical Nutrition, v. 33, n. 1, p. 136-142, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.clnu.2013.04.001. Acesso em: 07 jul. 2024.
APA
Urata, Y. N., Lyra, E. C. de, Katayama, M. L. H., Basso, R. A., Assis, P. E. Z. de, Cardoso, A. P. T., et al. (2014). Calcitriol supplementation effects on Ki67 expression and transcriptional profile of breast cancer specimens from post-menopausal patients. Clinical Nutrition, 33( 1), 136-142. doi:10.1016/j.clnu.2013.04.001
NLM
Urata YN, Lyra EC de, Katayama MLH, Basso RA, Assis PEZ de, Cardoso APT, Roela RA, Nonogaki S, Góes JCGS, Brentani MM, Folgueira MAAK. Calcitriol supplementation effects on Ki67 expression and transcriptional profile of breast cancer specimens from post-menopausal patients [Internet]. Clinical Nutrition. 2014 ; 33( 1): 136-142.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1016/j.clnu.2013.04.001
Vancouver
Urata YN, Lyra EC de, Katayama MLH, Basso RA, Assis PEZ de, Cardoso APT, Roela RA, Nonogaki S, Góes JCGS, Brentani MM, Folgueira MAAK. Calcitriol supplementation effects on Ki67 expression and transcriptional profile of breast cancer specimens from post-menopausal patients [Internet]. Clinical Nutrition. 2014 ; 33( 1): 136-142.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1016/j.clnu.2013.04.001
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTOS, Elen Pereira et al. MicroRNAs discriminate familial from sporadic non-BRCA1/2 breast carcinoma arising in patients <= 35 Years. PLOS ONE, v. 9, n. 7, 2014Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0101656. Acesso em: 07 jul. 2024.
APA
Bastos, E. P., Brentani, H., Pasini, F. S., Silva, A. R. T. da, Tôrres, C. H., Puga, R. D., et al. (2014). MicroRNAs discriminate familial from sporadic non-BRCA1/2 breast carcinoma arising in patients <= 35 Years. PLOS ONE, 9( 7). doi:10.1371/journal.pone.0101656
NLM
Bastos EP, Brentani H, Pasini FS, Silva ART da, Tôrres CH, Puga RD, Olivieri EHR, Piovezani AR, Pereira CA de B, Lima AM, Carraro DM, Brentani MM. MicroRNAs discriminate familial from sporadic non-BRCA1/2 breast carcinoma arising in patients<= 35 Years [Internet]. PLOS ONE. 2014 ; 9( 7):[citado 2024 jul. 07 ] Available from: https://doi.org/10.1371/journal.pone.0101656
Vancouver
Bastos EP, Brentani H, Pasini FS, Silva ART da, Tôrres CH, Puga RD, Olivieri EHR, Piovezani AR, Pereira CA de B, Lima AM, Carraro DM, Brentani MM. MicroRNAs discriminate familial from sporadic non-BRCA1/2 breast carcinoma arising in patients<= 35 Years [Internet]. PLOS ONE. 2014 ; 9( 7):[citado 2024 jul. 07 ] Available from: https://doi.org/10.1371/journal.pone.0101656
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEL VALLE, Paulo Roberto et al. Transcriptional profile of fibroblasts obtained from the primary site, lymph node and bone marrow of breast cancer patients. Genetics and Molecular Biology, v. 37, n. 3, p. 480-489, 2014Tradução . . Disponível em: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171766/. Acesso em: 07 jul. 2024.
APA
Del Valle, P. R., Milani, C., Brentani, M. M., Katayama, M. L. H., Lyra, E. C. de, Carraro, D. M., et al. (2014). Transcriptional profile of fibroblasts obtained from the primary site, lymph node and bone marrow of breast cancer patients. Genetics and Molecular Biology, 37( 3), 480-489. doi:10.1590/s1415-47572014000400002
NLM
Del Valle PR, Milani C, Brentani MM, Katayama MLH, Lyra EC de, Carraro DM, Brentani H, Puga R, Lima LA, Rozenchan PB, Nunes B dos S, Goés JCGS, Folgueira MAK. Transcriptional profile of fibroblasts obtained from the primary site, lymph node and bone marrow of breast cancer patients [Internet]. Genetics and Molecular Biology. 2014 ; 37( 3): 480-489.[citado 2024 jul. 07 ] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171766/
Vancouver
Del Valle PR, Milani C, Brentani MM, Katayama MLH, Lyra EC de, Carraro DM, Brentani H, Puga R, Lima LA, Rozenchan PB, Nunes B dos S, Goés JCGS, Folgueira MAK. Transcriptional profile of fibroblasts obtained from the primary site, lymph node and bone marrow of breast cancer patients [Internet]. Genetics and Molecular Biology. 2014 ; 37( 3): 480-489.[citado 2024 jul. 07 ] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171766/
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MILANI, Cintia et al. Transcriptional effects of 1,25 dihydroxyvitamin D3 physiological and supra-physiological concentrations in breast cancer organotypic culture. BMC Cancer, v. 13, n. 119, p. (online), 2013Tradução . . Disponível em: https://doi.org/10.1186/1471-2407-13-119. Acesso em: 07 jul. 2024.
APA
Milani, C., Katayama, M. L. H., Lyra, E. C. de, Welsh, J. E., Campos, L. T., Brentani, M. M., et al. (2013). Transcriptional effects of 1,25 dihydroxyvitamin D3 physiological and supra-physiological concentrations in breast cancer organotypic culture. BMC Cancer, 13( 119), (online). doi:10.1186/1471-2407-13-119
NLM
Milani C, Katayama MLH, Lyra EC de, Welsh JE, Campos LT, Brentani MM, Maciel M do S, Roela RA, Valle PR del, Góes JCGS, Nonogaki S, Tamura RE, Folgueira MAAK. Transcriptional effects of 1,25 dihydroxyvitamin D3 physiological and supra-physiological concentrations in breast cancer organotypic culture [Internet]. BMC Cancer. 2013 ; 13( 119): (online).[citado 2024 jul. 07 ] Available from: https://doi.org/10.1186/1471-2407-13-119
Vancouver
Milani C, Katayama MLH, Lyra EC de, Welsh JE, Campos LT, Brentani MM, Maciel M do S, Roela RA, Valle PR del, Góes JCGS, Nonogaki S, Tamura RE, Folgueira MAAK. Transcriptional effects of 1,25 dihydroxyvitamin D3 physiological and supra-physiological concentrations in breast cancer organotypic culture [Internet]. BMC Cancer. 2013 ; 13( 119): (online).[citado 2024 jul. 07 ] Available from: https://doi.org/10.1186/1471-2407-13-119
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHILE, Thais et al. HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis. BMC Cancer, v. 13, n. 451, p. (online), 2013Tradução . . Disponível em: https://doi.org/10.1186/1471-2407-13-451. Acesso em: 07 jul. 2024.
APA
Chile, T., Fortes, M. A. H. Z., Corrêa-Giannella, M. L. C., Brentani, H. P., Maria, D. A., Puga, R. D., et al. (2013). HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis. BMC Cancer, 13( 451), (online). doi:10.1186/1471-2407-13-451
NLM
Chile T, Fortes MAHZ, Corrêa-Giannella MLC, Brentani HP, Maria DA, Puga RD, Paula V de JR de, Kubrusly MS, Novak EM, Bacchella T, Giorgi RR. HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis [Internet]. BMC Cancer. 2013 ; 13( 451): (online).[citado 2024 jul. 07 ] Available from: https://doi.org/10.1186/1471-2407-13-451
Vancouver
Chile T, Fortes MAHZ, Corrêa-Giannella MLC, Brentani HP, Maria DA, Puga RD, Paula V de JR de, Kubrusly MS, Novak EM, Bacchella T, Giorgi RR. HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis [Internet]. BMC Cancer. 2013 ; 13( 451): (online).[citado 2024 jul. 07 ] Available from: https://doi.org/10.1186/1471-2407-13-451
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOLGUEIRA, Maria Aparecida Azevedo Koike et al. Markers of breast cancer stromal fibroblasts in the primary tumor site associated with lymph node metastasis: a systematic review including our cases series. Bioscience Reports, v. 33, n. 6, p. 921-929, 2013Tradução . . Disponível em: http://www.bioscirep.org/bsr/033/e085/033e085.pdf. Acesso em: 07 jul. 2024.
APA
Folgueira, M. A. A. K., Maistro, S., Katayama, M. L. H., Roela, R. A., Mundim, F. G. L., Nanogaki, S., et al. (2013). Markers of breast cancer stromal fibroblasts in the primary tumor site associated with lymph node metastasis: a systematic review including our cases series. Bioscience Reports, 33( 6), 921-929. doi:10.1042/BSR20130060
NLM
Folgueira MAAK, Maistro S, Katayama MLH, Roela RA, Mundim FGL, Nanogaki S, Bock GH de, Brentani MM. Markers of breast cancer stromal fibroblasts in the primary tumor site associated with lymph node metastasis: a systematic review including our cases series [Internet]. Bioscience Reports. 2013 ; 33( 6): 921-929.[citado 2024 jul. 07 ] Available from: http://www.bioscirep.org/bsr/033/e085/033e085.pdf
Vancouver
Folgueira MAAK, Maistro S, Katayama MLH, Roela RA, Mundim FGL, Nanogaki S, Bock GH de, Brentani MM. Markers of breast cancer stromal fibroblasts in the primary tumor site associated with lymph node metastasis: a systematic review including our cases series [Internet]. Bioscience Reports. 2013 ; 33( 6): 921-929.[citado 2024 jul. 07 ] Available from: http://www.bioscirep.org/bsr/033/e085/033e085.pdf
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GROSSO, Stana Helena Giorgi et al. Breast cancer tissue slices as a model for evaluation of response to rapamycin. Cell Tissue Research, v. 352, n. 3, p. 671-684, 2013Tradução . . Disponível em: https://doi.org/10.1007%2Fs00441-013-1608-8. Acesso em: 07 jul. 2024.
APA
Grosso, S. H. G., Katayama, M. L. H., Roela, R. A., Nonogaki, S., Soares, F. A., Brentani, H., et al. (2013). Breast cancer tissue slices as a model for evaluation of response to rapamycin. Cell Tissue Research, 352( 3), 671-684. doi:10.1007%2Fs00441-013-1608-8
NLM
Grosso SHG, Katayama MLH, Roela RA, Nonogaki S, Soares FA, Brentani H, Lima L, Folgueira MAAK, Waitzberg AFL, Pasini FS, Góes JCGS, Brentani MM. Breast cancer tissue slices as a model for evaluation of response to rapamycin [Internet]. Cell Tissue Research. 2013 ; 352( 3): 671-684.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1007%2Fs00441-013-1608-8
Vancouver
Grosso SHG, Katayama MLH, Roela RA, Nonogaki S, Soares FA, Brentani H, Lima L, Folgueira MAAK, Waitzberg AFL, Pasini FS, Góes JCGS, Brentani MM. Breast cancer tissue slices as a model for evaluation of response to rapamycin [Internet]. Cell Tissue Research. 2013 ; 352( 3): 671-684.[citado 2024 jul. 07 ] Available from: https://doi.org/10.1007%2Fs00441-013-1608-8